Replicating genotype-phenotype associations

Nature

Volumn 447, Issue 7145, 2007, Pages 655-660

  Chanock, Stephen J ^a   Manolio, Teri ^b   Boehnke, Michael ^c   Boerwinkle, Eric ^d   Hunter, David J ^e   Thomas, Gilles ^a   Hirschhorn, Joel N ^f   Abecasis, Goncalo ^c   Altshuler, David ^f   Bailey Wilson, Joan E ^b   Brooks, Lisa D ^b   Cardon, Lon R ^g   Daly, Mark ^f   Donnelly, Peter ^h   Fraumeni Jr , Joseph F ^a   Freimer, Nelson B ⁱ   Gerhard, Daniela S ^a   Gunter, Chris ^j   Guttmacher, Alan E ^b   Guyer, Mark S ^b   Harris, Emily L ^b   Hoh, Josephine ^k   Hoover, Robert ^a   Kong, C Augustine ^l   Merikangas, Kathleen R ^m   Morton, Cynthia C ⁿ   Palmer, Lyle J ^o   Phimister, Elizabeth G ^j   Rice, John P ^p   Roberts, Jerry ^b   Rotimi, Charles ^q   Tucker, Margaret A ^a   Vogan, Kyle J ^j   Wacholder, Sholom ^a   Wijsman, Ellen M ^r   Winn, Deborah M ^a   Collins, Francis S ^b   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e CHANNING LABORATORY   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j University of Oxford ^*  (United States)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l DECODE GENETICS   (Iceland)

^m NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^p WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^r UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COMPLEMENT FACTOR H; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHODIESTERASE IV;

GENOTYPE; PHENOTYPE;

CANCER RISK; COMPARATIVE STUDY; CROHN DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34249997024     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/447655a     Document Type: Review

References (81)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431, 931-945 (2004).
2. The International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
3. Hinds, D. A. et al. Whole-genome patterns of common DNA variation in three human populations. Science 307, 1072-1079 (2005).
4. Hirschhorn, J. N., Lohmueller, K., Byrne, E. & Hirschhorn, K. A comprehensive review of genetic association studies. Genet. Med. 4, 45-61 (2002).
5. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A. & Contopoulos-Ioannidis, D. G. Replication validity of genetic association studies. Nature Genet. 29, 306-309 (2001).
6. Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33, 177-182 (2003).
7. Ioannidis, J. P. Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. J. Natl Cancer Inst. 98, 1350-1353 (2006).
8. Freely associating. Nature Genet. 22, 1-2 (1999).
9. Todd, J. A. Statistical false positive or true disease pathway? Nature Genet. 38, 731-733 (2006).
10. Neale, B. M. & Sham, P. C. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75, 353-362 (2004).
11. Clark, A. G., Boerwinkle, E., Hixson, J. & Sing, C. F. Determinants of the success of whole-genome association testing. Genome Res. 15, 1463-1467 (2005).
12. Freimer, N. B. & Sabatti, C. Human genetics: variants in common diseases. Nature 445, 828-830 (2007).
13. Altshuler, D. et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet. 26, 76-80 (2000).
14. Field, S. F. et al. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 50, 212-213 (2007).
15. Grant, S. F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 38, 320-323 (2006).
16. Groves, C. J. et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55, 2640-2644 (2006).
17. Saxena, R. et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55, 2890-2895 (2006).
18. Helgason, A. et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nature Genet. 39, 218-225 (2007).
19. Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
20. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
21. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
22. Economou, M., Trikalinos, T. A., Loizou, K. T., Tsianos, E. V. & Ioannidis, J. P. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 99, 2393-2404 (2004).
23. Edwards, A. O. et al. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424 (2005).
24. Hageman, G. S. et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA 102, 7227-7232 (2005).
25. Klein, R. J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (2005).
26. Haines, J. L. et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421 (2005).
27. Freedman, M. L. et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc. Natl Acad. Sci. USA 103, 14068-14073 (2006).
28. Amundadottir, L. T. et al. A common variant associated with prostate cancer in European and African populations. Nature Genet. 38, 652-658 (2006).
29. Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nature Genet. 39, 631-637 (2007).
30. Haiman, C. A. et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nature Genet. 39, 638-644 (2007).
31. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nature Genet. 39, 645-649 (2007).
32. Colhoun, H. M., McKeigue, P. M. & Davey, S. G. Problems of reporting genetic associations with complex outcomes. Lancet 361, 865-872 (2003).
33. Ioannidis, J. P., Trikalinos, T. A. & Khoury, M. J. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am. J. Epidemiol. 164, 609-614 (2006).
34. Straub, R. E. et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71, 337-348 (2002).
35. Van Den, B. A. et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 73, 1438-1443 (2003).
36. Bray, N. J. et al. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 14, 1947-1954 (2005).
37. Funke, B. et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 75, 891-898 (2004).
38. Kirov, G. et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol. Psychiatry 55, 971-975 (2004).
39. Mutsuddi, M. et al. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am. J. Hum. Genet. 79, 903-909 (2006).
40. Herbert, A. et al. A common genetic variant is associated with adult and childhood obesity. Science 312, 279-283 (2006).
41. Hall, D. H., Rahman, T., Avery, P. J. & Keavney, B. INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families. BMC Med. Genet. 7, 83 (2006).
42. Rosskopf, D. et al. Comment on 'A common genetic variant is associated with adult and childhood obesity'. Science 315, 187 (2007).
43. Dina, C. et al. Comment on 'A common genetic variant is associated with adult and childhood obesity'. Science 315, 187 (2007).
44. Loos, R. J., Barroso, I., O'rahilly, S. & Wareham, N. J. Comment on 'A common genetic variant is associated with adult and childhood obesity'. Science 315, 187 (2007).
45. Gretarsdottir, S., Gulcher, J., Thorleifsson, G., Kong, A. & Stefansson, K. Comment on the phosphodiesterase 4D replication study by Bevan et al. Stroke 36, 1824 (2005).
46. Rosand, J., Bayley, N., Rost, N. & de Bakker, P. I. Many hypotheses but no replication for the association between PDE4D and stroke. Nature Genet. 38, 1091-1092 (2006).
47. Manolio, T. A., Bailey-Wilson, J. E. & Collins, F. S. Genes, environment and the value of prospective cohort studies. Nature Rev. Genet. 7, 812-820 (2006).
48. Spielman, R. S. & Ewens, W. J. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59, 983-989 (1996).
49. Roeder, K., Bacanu, S. A., Wasserman, L. & Devlin, B. Using linkage genome scans to improve power of association in genome scans. Am. J. Hum. Genet. 78, 243-252 (2006).
50. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. & Rothman, N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst. 96, 434-442 (2004).
51. Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516-1517 (1996).
52. Risch, N. J. Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
53. Angell, M. The interpretation of epidemiologic studies. N. Engl. J. Med. 323, 823-825 (1990).
54. Clarke, R. et al. Lymphotoxin-? gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2, e107 (2006).
55. Zollner, S. & Pritchard, J. Overcoming the winner's curse: estimating penetrance parameters from case-control. Am. J. Hum. Genet. 80, 605-615 (2007).
56. Rothman, N. et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 7, 27-38 (2006).
57. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197 (1997).
58. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss. AREDS report no. 9. Arch. Ophthalmol. 119, 1439-1452 (2001).
59. Freimer, N. & Sabatti, C. The human phenome project. Nature Genet. 34, 15-21 (2003).
60. Flint, J. & Munafo, M. R. The endophenotype concept in psychiatric genetics. Psychol. Med. 37, 163-180 (2007).
61. Wacholder, S., Rothman, N. & Caporaso, N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J. Natl Cancer Inst. 92, 1151-1158 (2000).
62. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genet. 38, 904-909 (2006).
63. Chandak, G. R. et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50, 63-67 (2007).
64. Horikoshi, M. et al. A genetic variant of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologica 50, 747-751 (2007).
65. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
66. Maraganore, D. M. et al. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 77, 685-693 (2005).
67. Myers, D. R. Considerations for genomewide association studies in Parkinson disease. Am. J. Hum. Genet. 78, 1081-1082 (2006).
68. Clarimon, J. et al. Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. Am. J. Hum. Genet. 78, 1082-1084 (2006).
69. Farrer, M. J. et al. Genomewide association, Parkinson disease, and PARK10. Am. J. Hum. Genet. 78, 1084-1088 (2006).
70. Goris, A. et al. No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening. Am. J. Hum. Genet. 78, 1088-1090 (2006).
71. Li, Y. et al. A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan. Am. J. Hum. Genet. 78, 1090-1092 (2006).
72. Patterson, M. & Cardon, L. Replication publication. PLoS. Biol. 3, e327 (2005).
73. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nature Genet. Advance online publication, 27 May 2007 (doi:10.1038/ng2075).
74. Easton, D. F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature Advance online publication, 27 May 2007 (doi:10.1038/nature05887).
75. Skol, A. D., Scott, L. J., Abecasis, G. R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nature Genet. 38, 209-213 (2006).
76. Stacey, S. N. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nature Genet. Advance online publication, 27 May 2007 (doi:10.1038/ng2064)
77. Saxena, R. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
78. Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345 (2007).
79. Zeggini, E. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336-1341 (2007).
80. Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science Advance online publication, 3 May 2007 (doi:10.1126/science.1142842).
81. McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science Advance online publication, 3 May 2007 (doi:10.1126/science.1142447).